Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24167 | 321 | 37.7 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
456 | 3 | VIRGIN OLIVE OIL//OLIVE OIL//HYDROXYTYROSOL | 25234 |
1534 | 2 | OXIDIZED LDL//ATHEROSCLEROSIS//LOX 1 | 7455 |
24167 | 1 | BIOHYBRIDE SYST//HLTH EXERCISE//OXIDIZED LDL | 321 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BIOHYBRIDE SYST | address | 380501 | 1% | 100% | 4 |
2 | HLTH EXERCISE | address | 297252 | 3% | 31% | 10 |
3 | OXIDIZED LDL | authKW | 266307 | 17% | 5% | 53 |
4 | MCA | address | 250543 | 6% | 15% | 18 |
5 | DIENE CONJUGATION | authKW | 214024 | 2% | 38% | 6 |
6 | OXIDIZED LOW DENSITY LIPOPROTEIN | authKW | 191309 | 12% | 5% | 39 |
7 | IGM AND IGG MDA LDL AUTOANTIBODIES | authKW | 190250 | 1% | 100% | 2 |
8 | MALONDIALDEHYDE MODIFIED LDL | authKW | 190246 | 1% | 50% | 4 |
9 | MALONDIALDEHYDE MODIFIED LOW DENSITY LIPOPROTEIN | authKW | 182927 | 2% | 38% | 5 |
10 | ATHEROSCLEROSIS METAB UNIT | address | 148475 | 2% | 20% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 1819 | 22% | 0% | 72 |
2 | Cardiac & Cardiovascular System | 950 | 22% | 0% | 71 |
3 | Medical Laboratory Technology | 672 | 8% | 0% | 25 |
4 | Nutrition & Dietetics | 441 | 10% | 0% | 33 |
5 | Endocrinology & Metabolism | 196 | 11% | 0% | 34 |
6 | Medicine, Research & Experimental | 135 | 9% | 0% | 28 |
7 | Hematology | 103 | 6% | 0% | 20 |
8 | Sport Sciences | 51 | 3% | 0% | 11 |
9 | Medicine, General & Internal | 26 | 6% | 0% | 19 |
10 | Engineering, Biomedical | 19 | 2% | 0% | 8 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOHYBRIDE SYST | 380501 | 1% | 100% | 4 |
2 | HLTH EXERCISE | 297252 | 3% | 31% | 10 |
3 | MCA | 250543 | 6% | 15% | 18 |
4 | ATHEROSCLEROSIS METAB UNIT | 148475 | 2% | 20% | 8 |
5 | DIPARTIMENTO AREA SERV DIAGNOST | 126832 | 1% | 67% | 2 |
6 | ATHEROSCLEROSIS MET UNIT | 95125 | 0% | 100% | 1 |
7 | BIOMED BEHAV METHODOL CORE | 95125 | 0% | 100% | 1 |
8 | BLOEDINGS VAATZIEKTEN | 95125 | 0% | 100% | 1 |
9 | CLIN ATHEROSCLEROSIS CARDIOVAS DIS PREVEN | 95125 | 0% | 100% | 1 |
10 | CLIN MED CHEM DIAGNOST MED | 95125 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ATHEROSCLEROSIS | 6047 | 8% | 0% | 26 |
2 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 3246 | 5% | 0% | 16 |
3 | DIABETOLOGY & METABOLIC SYNDROME | 2483 | 1% | 1% | 4 |
4 | CLINICAL LIPIDOLOGY | 2235 | 1% | 1% | 3 |
5 | JOURNAL OF MEDICAL BIOCHEMISTRY | 1099 | 1% | 1% | 2 |
6 | JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION | 1012 | 2% | 0% | 5 |
7 | DISEASE MARKERS | 873 | 1% | 0% | 4 |
8 | NUTRITION JOURNAL | 779 | 1% | 0% | 3 |
9 | JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS | 762 | 1% | 0% | 3 |
10 | METABOLIC SYNDROME AND RELATED DISORDERS | 623 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TRPKOVIC, A , RESANOVIC, I , STANIMIROVIC, J , RADAK, D , MOUSA, SA , CENIC-MILOSEVIC, D , JEVREMOVIC, D , ISENOVIC, ER , (2015) OXIDIZED LOW-DENSITY LIPOPROTEIN AS A BIOMARKER OF CARDIOVASCULAR DISEASES.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 52. ISSUE 2. P. 70 -85 | 74 | 31% | 12 |
2 | LANKIN, V , VIIGIMAA, M , TIKHAZE, A , KUMSKOVA, E , KONOVALOVA, G , ABINA, J , ZEMTSOVSKAYA, G , KOTKINA, T , VLASIK, T , YANUSHEVSKAYA, E , (2011) CHOLESTEROL-RICH LOW DENSITY LIPOPROTEINS ARE ALSO MORE OXIDIZED.MOLECULAR AND CELLULAR BIOCHEMISTRY. VOL. 355. ISSUE 1-2. P. 187 -191 | 17 | 89% | 3 |
3 | FRALEY, AE , TSIMIKAS, S , (2006) CLINICAL APPLICATIONS OF CIRCULATING OXIDIZED LOW-DENSITY LIPOPROTEIN BIOMARKERS IN CARDIOVASCULAR DISEASE.CURRENT OPINION IN LIPIDOLOGY. VOL. 17. ISSUE 5. P. 502-509 | 25 | 56% | 89 |
4 | ITABE, H , UEDA, M , (2007) MEASUREMENT OF PLASMA OXIDIZED LOW-DENSITY LIPOPROTEIN AND ITS CLINICAL IMPLICATIONS.JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS. VOL. 14. ISSUE 1. P. 1 -11 | 25 | 46% | 70 |
5 | VERHOYE, E , LANGLOIS, MR , (2009) CIRCULATING OXIDIZED LOW-DENSITY LIPOPROTEIN: A BIOMARKER OF ATHEROSCLEROSIS AND CARDIOVASCULAR RISK?.CLINICAL CHEMISTRY AND LABORATORY MEDICINE. VOL. 47. ISSUE 2. P. 128-137 | 21 | 51% | 56 |
6 | VIIGIMAA, M , ABINA, J , ZEMTSOVSKAYA, G , TIKHAZE, A , KONOVALOVA, G , KUMSKOVA, E , LANKIN, V , (2010) MALONDIALDEHYDE-MODIFIED LOW-DENSITY LIPOPROTEINS AS BIOMARKER FOR ATHEROSCLEROSIS.BLOOD PRESSURE. VOL. 19. ISSUE 3. P. 164-168 | 11 | 92% | 14 |
7 | ISHIGAKI, Y , OKA, Y , KATAGIRI, H , (2009) CIRCULATING OXIDIZED LDL: A BIOMARKER AND A PATHOGENIC FACTOR.CURRENT OPINION IN LIPIDOLOGY. VOL. 20. ISSUE 5. P. 363-369 | 24 | 33% | 82 |
8 | SHIMADA, K , MOKUNO, H , MATSUNAGA, E , MIYAZAKI, T , SUMIYOSHI, K , MIYAUCHI, K , DAIDA, H , (2004) CIRCULATING OXIDIZED LOW-DENSITY LIPOPROTEIN IS AN INDEPENDENT PREDICTOR FOR CARDIAC EVENT IN PATIENTS WITH CORONARY ARTERY DISEASE.ATHEROSCLEROSIS. VOL. 174. ISSUE 2. P. 343-347 | 13 | 72% | 75 |
9 | HOLVOET, P , LEE, DH , STEFFES, M , GROSS, M , JACOBS, DR , (2008) ASSOCIATION BETWEEN CIRCULATING OXIDIZED LOW-DENSITY LIPOPROTEIN AND INCIDENCE OF THE METABOLIC SYNDROME.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 299. ISSUE 19. P. 2287-2293 | 15 | 45% | 150 |
10 | UEBA, T , NOMURA, S , NISHIKAWA, T , KAJIWARA, M , YAMASHITA, K , (2009) CIRCULATING OXIDIZED LDL, MEASURED WITH FOH1A/DLH3 ANTIBODY, IS ASSOCIATED WITH METABOLIC SYNDROME AND THE CORONARY HEART DISEASE RISK SCORE IN HEALTHY JAPANESE.ATHEROSCLEROSIS. VOL. 203. ISSUE 1. P. 243-248 | 16 | 53% | 10 |
Classes with closest relation at Level 1 |